Clinical article · Acute care, Specialties, Women, children and mental health

Dengue with warning signs: fluid management through the critical phase and recovery

Written for
Hospital physicians, emergency doctors and residents
Reading time
7 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • Record the day of illness and the WHO class at every review; the critical phase begins around defervescence, not after it.
  • A baseline haematocrit makes later values interpretable, and a rising haematocrit with a falling platelet count is a warning sign.
  • Crystalloid is the initial fluid, titrated to haematocrit, pulse pressure and urine output and stepped down as the patient stabilises.
  • Intravenous fluid is reduced and stopped in the recovery phase, when reabsorbed plasma causes overload.
  • Prophylactic platelet transfusion did not reduce bleeding in a randomised trial; NSAIDs, intramuscular injections and corticosteroids are avoided.
  • Malaria, leptospirosis, scrub typhus and bacterial sepsis can coexist with or mimic dengue and should be looked for.

The phase and the class come first

Dengue is endemic in more than 100 countries, and outbreaks can overwhelm health services [1]. There is no specific antiviral treatment: most symptomatic patients need careful observation and prompt but judicious intravenous fluid [2]. Two pieces of information drive almost every decision. The first is the WHO class, which places the patient as dengue without warning signs, dengue with warning signs, or severe dengue [3, 4]. The second is the phase of illness.

PhaseUsual timingWhat happensMain risk
FebrileFirst days of feverHigh fever and viraemia; the NS1 antigen test is most useful nowDehydration; warning signs missed
CriticalAround defervescence, usually days 3 to 7, lasting 24 to 48 hoursPlasma leakage, rising haematocrit, falling plateletsShock, bleeding, organ impairment
RecoveryThe following 2 to 3 daysLeaked fluid is reabsorbed; appetite and diuresis returnFluid overload and pulmonary oedema

Counting the day of illness from the first day of fever, and noting when the fever settles, is the most useful single habit. Defervescence marks the start of the period of greatest risk, not recovery.

Recognising warning signs

The WHO warning signs identify patients at risk of progressing to severe dengue:

  • Abdominal pain or tenderness
  • Persistent vomiting
  • Clinical fluid accumulation, such as pleural effusion or ascites
  • Mucosal bleeding
  • Lethargy or restlessness
  • Liver enlargement
  • A rising haematocrit together with a rapid fall in the platelet count

A meta-analysis found several of these signs associated with severe dengue in clinical practice [5], and another examined predictors of progression that can be detected during the febrile phase, when triage decisions are made [6]. Severe dengue is defined by severe plasma leakage leading to shock or respiratory distress, severe bleeding, or severe organ impairment [3].

Take a baseline haematocrit early, ideally in the febrile phase. Without it, a normal-looking value in a patient who started high can hide significant leakage.

Fluids through the critical phase

Patients with warning signs are usually admitted. Crystalloids are the initial fluid of choice [3]. Randomised trials in children with dengue shock compared crystalloids with colloids: in one small trial colloids restored cardiac index and haematocrit faster [8], while in a larger trial Ringer's lactate performed as well as the colloids tested for initial resuscitation of moderately severe shock [7].

  1. Take a haematocrit before starting fluids. In a patient who is not in shock, start isotonic crystalloid at a modest rate rather than with a large bolus.
  2. Reassess general condition, pulse, blood pressure and pulse pressure, capillary refill and urine output frequently, and repeat the haematocrit after each change of rate.
  3. If the observations improve and the haematocrit settles, step the rate down over the following hours, aiming for the least fluid that maintains perfusion and a urine output of about 0.5 mL/kg per hour.
  4. If the haematocrit keeps rising or the observations worsen, give a further measured bolus and review. If the patient deteriorates while the haematocrit falls, suspect bleeding and arrange blood.
  5. Reduce and stop intravenous fluid once the leak is over, usually within 24 to 48 hours of the start of the critical phase.

Rates, bolus volumes and monitoring intervals are set out in the WHO dengue guideline and, in India, in the national guidelines for the clinical management of dengue. Volumes for obese patients are usually calculated on ideal body weight. Local protocols take precedence.

Shock and severe dengue

Compensated shock may show only tachycardia, a narrowing pulse pressure, cool peripheries and delayed capillary refill with a normal systolic pressure; hypotension is a late sign. Severe dengue needs high-dependency or intensive care, crystalloid boluses with frequent reassessment, and colloid when shock persists despite crystalloid, as the guideline directs. A haematocrit that stays high or rises after a bolus suggests continuing leakage; one that falls sharply while the patient remains unstable suggests bleeding, which needs blood rather than more crystalloid. When shock does not respond, look for concealed bleeding, acidosis, hypoglycaemia and hypocalcaemia, and treat each one.

Recovery: the phase that causes overload

As the leak stops, extravasated fluid returns to the circulation. Fluid continued at the critical-phase rate then causes pleural effusions, ascites and pulmonary oedema, and overload is a recognised cause of harm late in the illness. Signs of recovery include stable observations, returning appetite, diuresis and a haematocrit that falls while the patient remains well. Intravenous fluid should then be reduced and stopped. New breathlessness or a widening pulse pressure in this phase points to overload rather than further leakage.

Platelets, drugs and other traps

Platelet counts often fall very low without significant bleeding. In a randomised trial in adults with dengue and 20,000 platelets per microlitre or fewer, without persistent mild or any severe bleeding, prophylactic platelet transfusion did not reduce clinical bleeding [9, 10], and it is not recommended [3]. More broadly, restrictive platelet transfusion strategies have not been shown to increase mortality or bleeding [12]. Platelets are given for significant bleeding or by the threshold in the national guideline, not for the count alone.

  • NSAIDs, aspirin and intramuscular injections, which add to the bleeding risk; paracetamol is used for fever and pain.
  • Corticosteroids, which have not shown benefit in a Cochrane review [11], and antibiotics without a separate indication.
  • A second infection: malaria, leptospirosis, scrub typhus or bacterial sepsis can coexist with or mimic dengue, so test for malaria in every febrile patient from an endemic area.
  • Treating a haematocrit number without the clinical picture, in either direction.
  • Overlooking higher-risk groups: pregnancy, infants and older adults, obesity, diabetes, kidney, heart or liver disease, and patients who live alone or far from hospital.

How Sana Health helps

The Tropical and Travel Medicine engine asks for the day of illness, serial haematocrit and platelet values, observations and warning signs, then states the WHO class and the phase in its conclusion. It sets out a fluid plan titrated to haematocrit, pulse pressure and urine output, says when to step fluids down in recovery, lists the drugs to avoid, and checks for coexisting malaria, leptospirosis or scrub typhus. It names the WHO or national guideline the plan follows, and local protocols take precedence.

Questions

What are the warning signs of dengue?

In the WHO classification they are abdominal pain or tenderness, persistent vomiting, clinical fluid accumulation, mucosal bleeding, lethargy or restlessness, liver enlargement, and a rising haematocrit with a rapid fall in platelets. Any of them usually means admission, close monitoring and intravenous fluid by the guideline.

When should platelets be transfused in dengue?

For significant bleeding, or by the threshold in the national guideline, rather than for a low count alone. A randomised trial in adults with 20,000 platelets per microlitre or fewer and no significant bleeding found that prophylactic transfusion did not reduce clinical bleeding.

Why does fluid overload happen in dengue?

Plasma leaks out of the circulation during the critical phase and returns during recovery. If intravenous fluid continues at the same rate once leakage stops, the returning fluid causes effusions, ascites and pulmonary oedema. Fluids should be stepped down as observations stabilise and the haematocrit falls.

References

  1. Dengue (opens in a new tab)Lancet, 2024
  2. Dengue (opens in a new tab)Lancet, 2019
  3. Management of Dengue: An Updated Review (opens in a new tab)Indian J Pediatr, 2023
  4. Comparing the usefulness of the 1997 and 2009 WHO dengue case classification: a systematic literature review (opens in a new tab)Am J Trop Med Hyg, 2014
  5. Clinical signs and symptoms associated with WHO severe dengue classification: a systematic review and meta-analysis (opens in a new tab)Emerg Microbes Infect, 2021
  6. Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis (opens in a new tab)Lancet Infect Dis, 2021
  7. Comparison of three fluid solutions for resuscitation in dengue shock syndrome (opens in a new tab)N Engl J Med, 2005
  8. Fluid replacement in dengue shock syndrome: a randomized, double-blind comparison of four intravenous-fluid regimens (opens in a new tab)Clin Infect Dis, 1999
  9. Prophylactic platelet transfusion plus supportive care versus supportive care alone in adults with dengue and thrombocytopenia: a multicentre, open-label, randomised, superiority trial (opens in a new tab)Lancet, 2017
  10. Predictors and Clinical Outcomes of Poor Platelet Recovery in Adult Dengue With Thrombocytopenia: A Multicenter, Prospective Study (opens in a new tab)Clin Infect Dis, 2020
  11. Corticosteroids for dengue infection (opens in a new tab)Cochrane Database Syst Rev, 2014
  12. Platelet Transfusion: 2025 AABB and ICTMG International Clinical Practice Guidelines (opens in a new tab)JAMA, 2025